Treatment
Treatment clinical trials
We’re tracking 8,312 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07645651RecruitingPhase 1
Samuraciclib for treatable basal pancreatic cancer
This trial tests a new drug called samuraciclib in people with a specific type of pancreatic cancer that can be removed with surgery or is confined to the pancreas. The drug may help stop the cancer from growing, and this study aims to see if it is safe and effective before surgery.
Seattle, WashingtonAges 18 years+ - NCT05910801RecruitingPhase 2
Tafasitamab plus lenalidomide and venetoclax for relapsed lymphoma
This Phase 2 trial studies tafasitamab together with lenalidomide and venetoclax in people with mantle cell lymphoma (MCL) that has come back or did not respond to prior treatment. It may help shrink the lymphoma and improve disease control when standard options have not worked.
Rochester, MinnesotaAges 18 years+ - NCT06691347Recruiting
Trauma treatment for adults with PTSD in Norway
This study tests if a type of therapy for trauma (EMDR or trauma-focused therapy) helps people with PTSD. It is for adults in Norway who have not had these treatments before.
Drammen, AkershusAges 18 years+ - NCT05398003Recruiting
Stimulating nerves to treat long-lasting neck and arm pain
This trial tests whether a nerve-stimulation treatment can reduce chronic neck and upper arm pain when other treatments haven’t worked. It includes adults who can consent and attend follow-up visits, and it checks for safety with pregnancy prevention and a specific early test after implantation.
NantesAges 18–85 - NCT06235463Recruiting
Pedal pump for leg lymphedema
This trial tests whether a foot pump can help reduce leg swelling in older adults with lymphedema. It is a low-risk, non-drug approach that you can do at home.
Stratford, New JerseyAges 55–100 - NCT06158477RecruitingPhase 1
A study of JYP0035 for advanced solid tumors
This trial tests a new drug called JYP0035 alone in people with advanced solid tumors. It aims to see if the drug is safe and effective.
Shanghai, Shanghai MunicipalityAges 18–74 - NCT06267508Recruiting
HIV testing and treatment for newborns
This study looks at ways to test and treat newborns for HIV early to improve their long-term health. It is for mothers with HIV whose babies are less than 3 days old and who are willing to have their babies tested and followed at home.
BeiraAges 18 years+ - NCT03944876RecruitingPhase 3
Botulinum toxin to block a facial nerve for chronic cluster headaches
This trial tests whether injections of botulinum toxin type A can reduce frequent, severe cluster headache attacks by targeting a facial nerve area. It’s for people whose cluster headaches have not responded well—or have caused side effects—to standard preventive treatments.
HamburgAges 18–85 - NCT06693245Recruiting
Pain during microwave treatment for varicose veins
This study looks at how much pain people feel during a microwave treatment for varicose veins in the leg. It aims to understand what factors affect pain, so the treatment can be more comfortable for future patients.
Chengdu, SichuanAges 18–90 - NCT07630506RecruitingPhase 2
Folinic Acid for Autism in Children Ages 3–10
This study tests whether folinic acid (a type of B vitamin) can help improve symptoms of autism in children. Researchers want to see if this supplement, combined with your child's current treatments, might make a difference.
Singapore, SingaporeAges 3–10 - NCT07629596RecruitingEarly Phase 1
mRNA CAR-T therapy for severe lupus or autoimmune anemia
This early-stage trial tests a new mRNA-based therapy called Arnovie101 that trains your immune cells to fight lupus (SLE) or autoimmune hemolytic anemia (AIHA) that haven't improved with standard treatments. The therapy may help reduce disease activity and symptoms.
Beijing, Beijing MunicipalityAges 18–60 - NCT07637188Recruiting
PLLA Injections for Loose Skin After Weight Loss Surgery
This trial tests injections to tighten and lift loose, sagging skin that develops after bariatric (weight loss) surgery. The injections use a substance called PLLA to stimulate your body's natural skin-rebuilding process.
SienaAges 18–60 - NCT07632404Enrolling by invitation
Switching to Once-Weekly Insulin: Blood Sugar Control and Satisfaction
This study looks at how well once-weekly insulin icodec controls blood sugar and improves quality of life for people with type 2 diabetes who currently take daily insulin injections. You'll switch from your daily insulin to a once-weekly injection and the study will track your blood sugar control, treatment satisfaction, and how well you stick with the new schedule.
Pescara, AbruzzoAges 18 years+ - NCT07631468Recruiting
Breast Surgery Follow-Up Study with Imaging Technology
This study follows patients who had breast surgery using special imaging tools (MOLLI, SPY-PHI, or SPY AGENT GREEN) to see how well these tools help surgeons and how patients recover. Your information helps doctors understand if these tools work safely and effectively.
Jacksonville, FloridaAges 18 years+ - NCT07632001Recruiting
Miro3D Wound Matrix for Diabetic Foot Ulcers
This trial tests a new wound-healing product called Miro3D to help diabetic foot ulcers heal better. You would receive this product along with standard wound care to see if it helps your ulcer close faster than standard treatment alone.
Phoenix, ArizonaAges 18 years+ - NCT07635186RecruitingPhase 2
AHB-137 injection for treatment-naïve chronic hepatitis B
This study tests a new injection called AHB-137 in people with chronic hepatitis B who have never received antiviral treatment. The goal is to see if it can help reduce the hepatitis B virus in the body and improve liver health.
Beijing, Beijing MunicipalityAges 18–65 - NCT05979818RecruitingPhase 1
Propranolol plus immunotherapy and chemo for advanced lung cancer
This trial tests adding a beta-blocker (propranolol) to a combination of immunotherapy (sintilimab) and standard chemotherapy for people with advanced non-small cell lung cancer that hasn't been treated before. The goal is to see if this new triple treatment helps shrink tumors better than chemo-immunotherapy alone.
Changsha, HunanAges 18–75 - NCT07633353Enrolling by invitation
Real-World Outcomes of a New Treatment for Advanced Kidney Cancer
This study looks at how well two newer cancer drugs (enfortumab vedotin and pembrolizumab) work together for advanced upper tract urothelial carcinoma—a rare kidney cancer. Researchers are collecting information from hospitals in France to understand how patients respond and what side effects occur in everyday care.
NîmesAges 18 years+ - NCT07636733Recruiting
Vitamin D for Gum and Bone Health in Periodontal Disease
This study tests whether vitamin D supplements can reduce inflammation and improve healing in people with gum disease, ranging from mild gingivitis to advanced periodontitis. Researchers will compare how vitamin D affects different stages of gum disease.
RizeAges 18–70 - NCT07634549RecruitingPhase 4
Plant-based albumin for low blood protein after liver surgery
This trial tests a new protein treatment made from rice to help patients recover from low blood protein levels that sometimes occur after liver surgery. The treatment may help your body heal better after the procedure.
Wuhan, HubeiAges 18–80 - NCT07633496Enrolling by invitation
Osteopathic hand therapy for healthy tears
This study tests whether gentle hands-on therapy (osteopathic manipulation) can change the makeup of your tears in a healthy way. It may help people who are interested in natural ways to support eye health.
Erie, PennsylvaniaAges 18 years+ - NCT07632352Recruiting
Acupuncture for Sudden Asthma Attacks
This trial tests whether acupuncture can help relieve symptoms during sudden, severe asthma attacks. Researchers want to see if this traditional treatment method can reduce breathing problems and improve recovery.
Zhengzhou, HenanAges 18 years+ - NCT07637487Recruiting
Tocotrienol supplement study for healthy middle-aged adults
This study tests whether tocotrienol, a form of vitamin E from palm oil, can help reduce aging-related cell damage in people aged 35–64. Researchers will check if this supplement is safe and effective for generally healthy adults.
Kuala Lumpur, Kuala LumpurAges 35–50 - NCT07635394Recruiting
Pregabalin for Irritable Bowel Syndrome Relief
This study tests whether pregabalin, a nerve-pain medication, can help reduce irritable bowel syndrome (IBS) symptoms like abdominal pain and irregular bowel habits. Researchers want to see if it's safe and effective for people with mild-to-moderate IBS.
Beijing, Beijing MunicipalityAges 18–70
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.